Different effects of pioglitazone and ro
β
Louiza Djaouti; Tony Jourdan; Laurent Demizieux; MichaΓ«l Chevrot; Joseph Gresti;
π
Article
π
2010
π
John Wiley and Sons
π
English
β 296 KB
## Abstract ## Background Pioglitazone (PIO) and rosiglitazone (ROSI) are widely used as oral antidiabetic agents for treatment of type 2 diabetes. Although these medications exert similar effects on blood glucose, recent clinical studies indicated that PIO has a more pronounced beneficial effect